Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-Term Quality of Life in Patients With Metastatic Melanoma Treated With Checkpoint Inhibitors

NCT03326973 is registered in ClinicalTrials.gov with Memorial Sloan Kettering Cancer Center as lead sponsor.

NCT NCT03326973
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03326973 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-Term Quality of Life in Patients With Metastatic Melanoma Treated With Checkpoint Inhibitors
Lead sponsor
Memorial Sloan Kettering Cancer Center
Phase
Observational
Overall status
Completed
Start date
October 25, 2017
Completion date
December 14, 2020
Enrollment
107 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic melanoma